Abstract
Burkitt lymphoma (BL) is a highly aggressive non-Hodgkin lymphoma revealing one of the highest proliferation rates in malignancies. Its frequent extranodal involvement and possible generalization to an acute leukemia challenge effective treatment which normally consists of a poly-agent chemotherapy. The following chapter sheds light on epidemiology, tumor biology, treatment options and prognosis of this lymphoma which has evolved from an enigmatic syndrome to a curable disease.
This is a preview of subscription content, log in via an institution.
References
Aramsri B, Piyaratn P, Kambhu P, Thitathan S. Burkitt’s tumour in a Thai patient. Int J Cancer. 1967;2:586–7.
Blum KA. Adult Burkitt leukemia and lymphoma. Blood. 2004;104:3009–20. https://doi.org/10.1182/blood-2004-02-0405.
Burkitt D. A sarcoma involving the jaws in African children. Br J Surg. 1958;46:218–23. https://doi.org/10.1002/bjs.18004619704.
Collins CD, Pullan JM, Tighe JR, Vanier TM. A case of Burkitt’s lymphoma in England. Int J Cancer. 1967;2:590–1.
Costa LJ, Xavier AC, Wahlquist AE, Hill EG. Trends in survival of patients with Burkitt lymphoma/leukemia in the USA: an analysis of 3691 cases. Blood. 2013;121:4861–6. https://doi.org/10.1182/blood-2012-12-475558.
Delemarre JF, Hollander CF, Frenkel M, de Leeuw-Israel FR. A case of a so-called “Burkitt tumor” in a Dutch boy. Int J Cancer. 1967;2:594–5.
Dunleavy K, Pittaluga S, Shovlin M, et al. Low-intensity therapy in adults with Burkitt’s lymphoma. N Engl J Med. 2013;369:1915–25. https://doi.org/10.1056/NEJMoa1308392.
Ersbøll J, Schultz HB, Thomsen BL, et al. Meningeal involvement in non-Hodgkin’s lymphoma: symptoms, incidence, risk factors and treatment. Scand J Haematol. 1985;35:487–96.
Haddy TB, Adde MA, Magrath IT. CNS involvement in small noncleaved-cell lymphoma: is CNS disease per se a poor prognostic sign? J Clin Oncol. 1991;9:1973–82. https://doi.org/10.1200/JCO.1991.9.11.1973.
Hall RK, Cussen LJ. Burkitt’s tumour – an Australian case. Int J Cancer. 1967;2:599–602.
Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361–92.
Hoelzer D, Ludwig W, Thiel E, et al. Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood. 1996;87:495.
Jourdain A, Auperin A, Minard-Colin V, et al. Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective “Lymphomes Malins B” protocols. A Société Française des Cancers de l’Enfant study. Haematologica. 2015;100:810–7. https://doi.org/10.3324/haematol.2014.121434.
Kim H, Park ES, Lee SH, et al. Clinical outcome of relapsed or refractory burkitt lymphoma and mature B-cell lymphoblastic leukemia in children and adolescents. Cancer Res Treat Off J Korean Cancer Assoc. 2014;46:358–65. https://doi.org/10.4143/crt.2013.047.
Lacasce A, Howard O, Li S, et al. Modified magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity. Leuk Lymphoma. 2004;45:761–7. https://doi.org/10.1080/1042819031000141301.
Lee EJ, Petroni GR, Schiffer CA, et al. Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251. J Clin Oncol Off J Am Soc Clin Oncol. 2001;19:4014–22. https://doi.org/10.1200/JCO.2001.19.20.4014.
Liang R, Chiu E, Loke SL. Secondary central nervous system involvement by non-Hodgkin’s lymphoma: the risk factors. Hematol Oncol. 1990;8:141–5.
Magrath IT, Lwanga S, Carswell W, Harrison N. Surgical reduction of tumour bulk in management of abdominal Burkitt’s lymphoma. Br Med J. 1974;2:308–12.
Magrath I, Adde M, Shad A, et al. Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol. 1996;14:925–34. https://doi.org/10.1200/JCO.1996.14.3.925.
Maramattom LV, Hari PN, Burns LJ, et al. Autologous and allogeneic transplantation for burkitt lymphoma outcomes and changes in utilization: a report from the center for international blood and marrow transplant research. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2013;19:173–9. https://doi.org/10.1016/j.bbmt.2012.11.016.
Martens C, Hodgson DC, Wells WA, et al. Outcome of hyperfractionated radiotherapy in chemotherapy-resistant non-Hodgkin’s lymphoma. Int J Radiat Oncol. 2006;64:1183–7. https://doi.org/10.1016/j.ijrobp.2005.09.030.
Mead GM, Sydes MR, Walewski J, et al. An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt’s lymphoma: results of United Kingdom Lymphoma Group LY06 study. Ann Oncol Off J Eur Soc Med Oncol. 2002;13:1264–74.
Mead GM, Barrans SL, Qian W, et al. A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial). Blood. 2008;112:2248–60. https://doi.org/10.1182/blood-2008-03-145128.
Molyneux EM, Rochford R, Griffin B, et al. Burkitt’s lymphoma. Lancet Lond Engl. 2012;379:1234–44. https://doi.org/10.1016/S0140-6736(11)61177-X.
Mukhtar F, Boffetta P, Risch HA, et al. Survival predictors of Burkitt’s lymphoma in children, adults and elderly in the United States during 2000-2013. Int J Cancer. 2017;140:1494–502. https://doi.org/10.1002/ijc.30576.
Murphy SB, Hustu HO. A randomized trial of combined modality therapy of childhood non-Hodgkin’s lymphoma. Cancer. 1980;45:630–7.
Norin T. Radiation therapy in Burkitt’s lymphoma: long term results. Acta Radiol Ther Phys Biol. 1977a;16:289–94. https://doi.org/10.3109/02841867709133949.
Norin T. Radiation therapy in Burkitt’s lymphoma of the central nervous system: primary results. Acta Radiol Ther Phys Biol. 1977b;16:73–80. https://doi.org/10.3109/02841867709133935.
Norin T, Onyango J. Radiotherapy in Burkitt’s lymphoma conventional or superfractionated regime – early results. Int J Radiat Oncol. 1977;2:399–406. https://doi.org/10.1016/0360-3016(77)90149-3.
Pilecki B, Kopiec P, Zajusz A, et al. Hyperfractionated radiotherapy for Burkitt-type lymphoma. Radiobiological aspects. Neoplasma. 1991;38:609–15.
Ribrag V, Koscielny S, Bosq J, et al. Rituximab and dose-dense chemotherapy for adults with Burkitt’s lymphoma: a randomised, controlled, open-label, phase 3 trial. Lancet. 2016;387:2402–11. https://doi.org/10.1016/S0140-6736(15)01317-3.
Rizzieri DA, Johnson JL, Niedzwiecki D, et al. Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of Cancer and Leukemia Group B study 9251. Cancer. 2004;100:1438–48. https://doi.org/10.1002/cncr.20143.
Shamberger RC, Weinstein HJ. The role of surgery in abdominal Burkitt’s lymphoma. J Pediatr Surg. 1992;27:236–40. https://doi.org/10.1016/0022-3468(92)90319-3.
Short NJ, Kantarjian HM, Ko H, et al. Outcomes of adults with relapsed or refractory Burkitt and high-grade B-cell leukemia/lymphoma: SHORT et al. Am J Hematol. 2017;92:E114–7. https://doi.org/10.1002/ajh.24720.
Soussain C, Patte C, Ostronoff M, et al. Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols. Blood. 1995;85:664–74.
Stein JE, Schwenn MR, Jacir NN, Harris BH. Surgical restraint in Burkitt’s lymphoma in children. J Pediatr Surg. 1991;26:1273–5. https://doi.org/10.1016/0022-3468(91)90596-L.
Teras LR, DeSantis CE, Cerhan JR, et al. 2016 US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J Clin. 2016;66:443–59. https://doi.org/10.3322/caac.21357.
Thomas DA, Cortes J, O’Brien S, et al. Hyper-CVAD program in Burkitt’s-type adult acute lymphoblastic leukemia. J Clin Oncol Off J Am Soc Clin Oncol. 1999;17:2461–70. https://doi.org/10.1200/JCO.1999.17.8.2461.
Thomas DA, Faderl S, O’Brien S, et al. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer. 2006;106:1569–80. https://doi.org/10.1002/cncr.21776.
World Health Organization (2017) WHO classification of tumours of haematopoietic and lymphoid tissues, revised 4th edition. International Agency for Research on Cancer, Lyon.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this entry
Cite this entry
Oertel, M., Micke, O., Eich, H.T. (2018). Radiation Therapy in Burkitt Lymphoma. In: Wenz, F. (eds) Radiation Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-52619-5_25-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-52619-5_25-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-52619-5
Online ISBN: 978-3-319-52619-5
eBook Packages: Springer Reference MedicineReference Module Medicine